Search for: "losartan" Results 1 - 20 of 74
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Jan 2019, 6:06 am by m zamora
Another drug company has recalled a version of losartan blood pressure medication over concerns the drug contains tiny amounts of a carcinogen. [read post]
22 Nov 2010, 1:24 pm by FDABlog HPM
Circuit ruled in a 2-1 decision concerning 180-day exclusivity for generic COZAAR (losartan potassium) Tablets and HYZAAR (hydrochlorothiazide; losartan potassium) Tablets that a mere patent delisting request is not enough to trigger a forfeiture event under the failure-to-market forfeiture provision at FDC Act § 505(j)(5)(D)(i)(I), and that there is “no reason to conclude that the 2003 addition of forfeiture provisions meant to give the brand manufacturer a… [read post]
4 Feb 2019, 6:19 am by Robert Kraft
This summer pharmaceutical companies started “recalling dozens of lots of the blood pressure and heart medications called valsartan, losartan and irbesartan after testing found the drugs had trace amounts of cancer-causing impurities,” reports USA Today. [read post]
12 Apr 2019, 11:23 am by Litigation news
It began last July when the FDA announced that it was recalling some generic blood pressure drugs, including Valsartan and Losartan, due to contamination with a potential cancer-causing compound called nitrosamine. [read post]
10 Jan 2010, 6:40 pm by Varun R. Chhonkar
This year at least 20 odd drug molecules will be going off-patent in the United States including (1) Merck’s anti-hypertension molecule Losartan, active ingredient of Cozaar and Hyzaar franchise, (2) Eisai’s anti-dementia molecule Donepezil, active ingredient of Aricept and Aricept ODT (3) Sanofi-Aventis’s anti-cancer molecule Docetaxel, active ingredient of Taxotere franchise, (4) Pfizer’s [read post]
8 Oct 2019, 11:17 am by Patrick A. Malone
Tens of millions of Americans may have been startled in recent days by the much-publicized pulling from the shelves of widely used drugs like ranitidine (aka Zantac), an over-the-counter heartburn remedy, and select lots of the prescription blood-pressure medications losartan, valsartan and irbesartan. [read post]
13 May 2019, 1:10 pm by Litigation news
They include certain versions of valsartan and two other blood pressure drugs, losartan and irbesartan, as well as other blood pressure medications that contain the recalled drugs in their formulations. [read post]
9 Apr 2010, 8:30 am by Lucas A. Ferrara, Esq.
Losartan potassium tablets and losartan potassium and hydrochlorothiazide tablets (a combination drug) are the generic equivalents of Cozaar and Hyzaar tablets, respectively. [read post]
30 Nov 2022, 11:00 pm by Thaddeus Mason Pope, JD, PhD
While treating her sepsis, clinicians stopped Lan's aspirin, losartan, and Lasix. [read post]
14 May 2010, 1:13 am
He believes that Losartan doesn't have an indefinite shelf life and that, therefore, it's a good idea to get it to its destination sooner rather than later. [read post]
9 Jan 2019, 7:59 am by Lebowitz & Mzhen
The FDA advised patients taking Losartan to contact their pharmacist or physician to discuss alternatives to Losartan, at least until the manufacturing problem has been resolved. [read post]
15 Apr 2010, 4:27 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/   Highlights this week included: CAFC denies Vanderbilt’s claim to Cialis patent right: Vanderbilt University v ICOS Corporation (Patently-O) (IPBiz) Paris District Court: Basic patent for Losartan covers any product comprising Losartan: Du Pont v Mylan Losartan SPC case (EPLAW)   General WHO documents from counterfeit… [read post]
8 Oct 2009, 6:05 am
 Have the inventor make a secret side deal (Patent Baristas) US: Governors send letter to Congressional leaders in support of 12-year data exclusivity period (Patent Docs) US Congress urged to act on biosimilars (GenericsWeb) US: Hal Wegner wakes up ACI Biotech Patents Forum in Boston – KSR and biotech claims (BioTechnology Patent Law)   Products Amrix (Cyclobenzaprine) – US: Eurand files patent infringement suit in C D California against Anchen following Para… [read post]
19 Jul 2010, 5:29 am by Mark Zamora
Just a short time after a meta-analysis suggested angiotensin receptor blockers (ARBs) for hypertension may increase cancer risk, the FDA has said it will conduct a safety review.The agency emphasized that patients now receiving these agents may stay on them and that physicians could write new prescriptions.The studies included data on four of the seven available ARB agents -- losartan (Cozaar), candesartan (Atacand), telmisartan (Micardis), and valsartan (Diovan). [read post]
17 Aug 2011, 6:31 pm by Glenn Reynolds
The quantity of this protein appears to decrease with age, but treating older mice with the blood pressure medication losartan can increase protein numbers to youthful levels, decreasing both blood pressure and cellular energy usage.” Faster, please. [read post]
1 Dec 2012, 8:00 pm by Lawrence B. Ebert
For example, losartan for valsartan (Diovan). [read post]